公开(公告)号：US20230204484A1

公开(公告)日：2023-06-29

申请号：US18109231

申请日：2023-02-13

申请人： Bridging Biosciences, LLC

发明人： Michael W. Jones ,  Tapley Holland

IPC分类号： G01N11/08

CPC分类号： G01N11/08

摘要： This invention relates in general to the field of cell-therapy treatments and more particularly, but not by way of limitation, to systems and methods for validating personalized cell-therapy treatments. In various embodiments, the system may calculate an aspiration volume needed for centrifugation to achieve a concentrated target threshold dose for a particular cell therapy using various factors such as, for example, information about a patient and the efficiency of the concentration process. In various embodiments, the system may also provide an indication to a physician of relevant published cell therapies to assist the physician in administering a treatment protocol.